Liver Transplant Rejection drugs in development, 2023

GlobalData tracks 16 drugs in development for Liver Transplant Rejection by 14 companies/universities/institutes. The top development phase for Liver Transplant Rejection is phase ii, with six drugs in that stage.

Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer

SEOUL, South Korea — Treatment with the bispecific antibody ubamatamab alone or in combination with the PD-1 inhibitor cemiplimab (Libtayo) appeared to be safe and

November 10, 2023

Report: How Private Equity Firms Raided Safety Net Hospitals

What You Should Know: – A new investigation by the Private Equity Stakeholder Project (PESP) reveals, for the first time, private equity (PE) investors were

July 21, 2023

Increased daily step count may reduce the risk of death and cardiovascular disease

Every additional step up to around 10,000 steps per day reduces the risk of death and cardiovascular disease (CVD), regardless of how much remaining time

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.